Comments
Loading...
Nurix Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:NRIX | Benzinga
Nurix Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 9
EPS Estimate
$-0.680
Quarterly Revenue Estimate
$14.78M
Annual Revenue
(as of Nov 30)
(as of Nov 30)
$54.55M
Analyze the earnings history of Nurix Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Nurix Therapeutics (NRIX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-01-28 | $-0.75 | $-0.71 | -5.63 % |
| Q3 | 2024-10-11 | $-0.67 | $-0.72 | 6.94 % |
| Q2 | 2024-07-11 | $-0.71 | $-0.64 | -10.9 % |
| Q1 | 2024-04-10 | $-0.76 | $-0.80 | 5.00 % |
Nurix Therapeutics (NRIX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-01-28 | $13.28M | $12.86M | 3.31 % |
| Q3 | 2024-10-11 | $12.59M | $15.76M | -20.1 % |
| Q2 | 2024-07-11 | $12.09M | $22.89M | -47.2 % |
| Q1 | 2024-04-10 | $16.59M | $16.64M | -0.33 % |
FAQ
When is Nurix Therapeutics (NASDAQ:NRIX) reporting earnings?
Nurix Therapeutics (NRIX) is scheduled to report earnings on April 9, 2025. The last reported earnings were for reported on January 28, 2025 for Q4.
What were the latest earnings per share (EPS) for Nurix Therapeutics (NASDAQ:NRIX)?
The Actual EPS was $-0.75, which missed the estimate of $-0.71.
What were Nurix Therapeutics’s (NASDAQ:NRIX) revenues?
The Actual Revenue was $13.3M, which beat the estimate of $12.9M.
Browse earnings estimates, EPS, and revenue on all stocks.